Anti-human Integrin aVb3 (Etaracizumab Biosimilar) Size:20 mg They are designated at type

They are designated at type I (slow twitch) and type II (fast twitch)

Hemopoietic MBP

PSA attachment to NCAM is associated with inhibited adhesion of neural cells

mast cell and eosinophil infiltration

Anti-human Integrin aVb3 (Etaracizumab Biosimilar) Size:20 mg They are designated at typeApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Integrin aVb3 Target Uniprot NA Overview Catalog# BIO0690SM Product Name Anti human Integrin aVb3 (Etaracizumab Biosimilar) Specifications Conjugation None Clone# Etaracizumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O